1
/
of
1
Elabscience
SKU:PKSH033859
Recombinant Human IL-23 alpha & Mouse IL-12 beta Heterodimer (C-6His)
Recombinant Human IL-23 alpha & Mouse IL-12 beta Heterodimer (C-6His)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS), a cutting-edge product that revolutionizes the field of immunology. This meticulously engineered heterodimer combines the potent properties of human IL-23 alpha and mouse IL-12 beta, resulting in a powerful and versatile tool for research and therapeutic applications.
The Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) is produced using state-of-the-art recombinant DNA technology, ensuring high purity and biological activity. This heterodimer is composed of two subunits, human IL-23 alpha and mouse IL-12 beta, which are covalently linked to form a stable and functional complex. The presence of a C-terminal 6-His tag facilitates easy purification and detection of the heterodimer.
This product exhibits exceptional stability and solubility, making it suitable for a wide range of experimental settings. Its unique composition enables the investigation of complex immunological processes, including the regulation of T-cell differentiation, cytokine production, and immune response modulation. Furthermore, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) has demonstrated remarkable efficacy in preclinical studies, highlighting its potential as a therapeutic agent for various immune-related disorders.
Researchers and scientists can utilize this heterodimer to unravel the intricate mechanisms underlying immune system function and dysregulation. Its application extends to the development of novel immunotherapies, vaccine adjuvants, and targeted drug delivery systems. With its exceptional purity, stability, and biological activity, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) is an indispensable tool for advancing immunological research and therapeutic interventions.
In conclusion, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) represents a breakthrough in the field of immunology. Its unique composition, high purity, and exceptional stability make it an invaluable asset for researchers and scientists seeking to unravel the complexities of the immune system and develop innovative therapeutic strategies.
The Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) is produced using state-of-the-art recombinant DNA technology, ensuring high purity and biological activity. This heterodimer is composed of two subunits, human IL-23 alpha and mouse IL-12 beta, which are covalently linked to form a stable and functional complex. The presence of a C-terminal 6-His tag facilitates easy purification and detection of the heterodimer.
This product exhibits exceptional stability and solubility, making it suitable for a wide range of experimental settings. Its unique composition enables the investigation of complex immunological processes, including the regulation of T-cell differentiation, cytokine production, and immune response modulation. Furthermore, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) has demonstrated remarkable efficacy in preclinical studies, highlighting its potential as a therapeutic agent for various immune-related disorders.
Researchers and scientists can utilize this heterodimer to unravel the intricate mechanisms underlying immune system function and dysregulation. Its application extends to the development of novel immunotherapies, vaccine adjuvants, and targeted drug delivery systems. With its exceptional purity, stability, and biological activity, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) is an indispensable tool for advancing immunological research and therapeutic interventions.
In conclusion, the Recombinant Human IL-23 Alpha & Mouse IL-12 Beta Heterodimer (C-6HIS) represents a breakthrough in the field of immunology. Its unique composition, high purity, and exceptional stability make it an invaluable asset for researchers and scientists seeking to unravel the complexities of the immune system and develop innovative therapeutic strategies.
Share
